हिंदी में पढ़ें

Home
/Cipla

Cipla

Cipla subsidiary to acquire South Africa’s Actor Pharma

Cipla subsidiary to acquire South Africa’s Actor Pharma

Tue, September 5, 2023

Cipla shares drop after FDA temporarily suspends licence for Patalganga manufacturing facility in Maharashtra

Cipla shares drop after FDA temporarily suspends licence for Patalganga manufacturing facility in Maharashtra

Thu, August 17, 2023

Blackstone likely to acquire promoter stake in Cipla: What is Blackstone? Its history, big acquisitions and controversies

Blackstone likely to acquire promoter stake in Cipla: What is Blackstone? Its history, big acquisitions and controversies

Fri, August 4, 2023

Cipla clarifies on reports of promoters looking to sell part stake

Cipla clarifies on reports of promoters looking to sell part stake

Fri, July 28, 2023

Cipla shares zoom 14% as company's Q1 PAT jumps 41.34% to Rs 998.07 crore—should you buy, sell, or hold?

Cipla shares zoom 14% as company's Q1 PAT jumps 41.34% to Rs 998.07 crore—should you buy, sell, or hold?

Thu, July 27, 2023

Cipla Q1 results: Consolidated PAT up by 41.34% at Rs 998.07 crore

Cipla Q1 results: Consolidated PAT up by 41.34% at Rs 998.07 crore

Wed, July 26, 2023

RECOMMENDED

Cipla Q4: Net profit jumps 45% YoY to Rs 526 crore; final dividend of Rs 8.5/share declared

Cipla Q4: Net profit jumps 45% YoY to Rs 526 crore; final dividend of Rs 8.5/share declared

Fri, May 12, 2023

Cipla dividend: Board announces Rs 8.5 dividend

Cipla dividend: Board announces Rs 8.5 dividend

Fri, May 12, 2023

Cipla Q4 Results: What Are The Expectations & Triggers In Q4? Watch Here

Cipla Q4 Results: What Are The Expectations & Triggers In Q4? Watch Here

Thu, May 11, 2023

Cipla Q4 2023 preview: EBITDA likely to increase 54% YoY, net profit may grow 88%

Cipla Q4 2023 preview: EBITDA likely to increase 54% YoY, net profit may grow 88%

Thu, May 11, 2023

Cipla, Lupin, Glenmark other pharma stocks stuck in narrow range after NPPA revises price of 25 drug formulations

Cipla, Lupin, Glenmark other pharma stocks stuck in narrow range after NPPA revises price of 25 drug formulations

Tue, March 28, 2023

Traders' Diary: Buy, sell or hold strategy on Cipla, Godrej Consumer, UltraTech Cement, ONGC, AB Capital, and 15 other stocks today

Traders' Diary: Buy, sell or hold strategy on Cipla, Godrej Consumer, UltraTech Cement, ONGC, AB Capital, and 15 other stocks today

Tue, March 28, 2023

Top Gainers & Losers: Cipla and Apollo Hospitals among major winners, Hindalco drops over 2%

Top Gainers & Losers: Cipla and Apollo Hospitals among major winners, Hindalco drops over 2%

Fri, March 24, 2023

Stocks in focus today: Maruti Suzuki, Bajaj Auto, Cipla, NBCC, RailTel, other stocks worth tracking

Stocks in focus today: Maruti Suzuki, Bajaj Auto, Cipla, NBCC, RailTel, other stocks worth tracking

Wed, March 15, 2023

Cipla inks pact to sell 51% stake in Uganda-based unit to Africa Capitalworks

Cipla inks pact to sell 51% stake in Uganda-based unit to Africa Capitalworks

Wed, March 15, 2023

Lupin, Sun Pharma shrug off sea of red on Dalal Street; here's what driving the gains

Lupin, Sun Pharma shrug off sea of red on Dalal Street; here's what driving the gains

Tue, March 14, 2023

Top Gainers & Losers: Apollo Hospitals, Cipla rally; M&M cracks over 3%

Top Gainers & Losers: Apollo Hospitals, Cipla rally; M&M cracks over 3%

Thu, March 9, 2023

Cipla Shares Under Pressure As 4 Brokerages Cut Target Prices In 2 Days - What's Worrying Analysts?

Cipla Shares Under Pressure As 4 Brokerages Cut Target Prices In 2 Days - What's Worrying Analysts?

Thu, March 9, 2023

Cipla shares under pressure as 4 brokerages cut target prices in 2 days — what's worrying analysts

Cipla shares under pressure as 4 brokerages cut target prices in 2 days — what's worrying analysts

Wed, March 8, 2023

Should you buy, sell or hold Bajaj Auto, Cipla, Larsen & Toubro, Grasim, power stocks?

Should you buy, sell or hold Bajaj Auto, Cipla, Larsen & Toubro, Grasim, power stocks?

Wed, March 8, 2023

2
3
4
5
6

Top News